Navigation Links
Sangui Bio Tech International Inc. Shareholders' Meeting Delayed to Include FY 2008 Report
Date:9/17/2008

WITTEN, Germany, September 17 /PRNewswire/ -- Sangui BioTech International, Inc., is currently preparing its financial statements for its 2008 financial year (ended June 30, 2008). The ensuing report on form 10KSB will be filed with the SEC and made public in due course. It will be included in the proxy materials for the forthcoming annual shareholders' meeting. This was also requested in a letter by the SEC. Subsequently, the shareholders' meeting will be delayed by a few weeks. Shareholders will be informed about the new schedule immediately after the pertaining resolutions will have been passed by the Board of directors.

SanguiBioTech GmbH is a wholly owned subsidiary of Sangui BioTech International, Inc. (http://www.pinksheets.com: SGBI)

Some of the statements contained in this news release discuss future expectations, contain projections of results of operation or financial condition or state other "forward-looking" information. These statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The forward-looking information is based on various factors and is derived using numerous assumptions. Important factors that may cause actual results to differ from projections include, among many others, the ability of the Company to raise sufficient capital to meet operating requirements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and variations of such words and similar expressions are intended to identify such forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information please contact:

Joachim Fleing

Phone: +49-(160)-741-27-17


'/>"/>
SOURCE Sangui Bio Tech International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangui BioTech International, Inc. Files Remaining Reports
2. Investors Acquire Share in Sangui BioTech GmbH
3. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
4. Sangui Partnership Enters a New Phase:
5. China Yingxia International, Inc. Appoints New Vice President of Finance
6. Yongye Biotechnology International Raises $9.4 Million in Private Placement
7. PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
8. Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences
9. Singapore to hold international pow-wow
10. Mindray Medical International Announces Second Quarter 2008 Results
11. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ov. 30 Dr. Jessica Torrente, Assis...niversity Medical Center in Washington, D.C., demo...c Gamma Imaging (BSGI) in clinical practice as an ...st cancer today at the annual meeting of the Radio...e purpose of the exhibit was to demonstrate how BS...
(Date:11/30/2009)...TTLE, Nov. 30 Cell Thera...ed today that its new class of platinum-based anti...ted a stronger anti-tumor potency and activity com...nds as well as the ability to overcome cisplatin-r...presented in a paper titled "Novel Bis-platinum Co...
(Date:11/29/2009)...ailable in German . , The concept of confin...s. The most famous example is that of quarks which...rof. Bella Lake from Helmholtz-Zentrum Berlin toge...rt for the first time an experimental realization ...a condensed matter system. , The concept of conf...
(Date:11/26/2009)... Ind. - A new generation of ultrasmall transistors...tures called semiconducting nanowires are closer t...IBM, Purdue University and the University of Calif...rned how to create nanowires with layers of differ...ic level, which is a critical requirement for maki...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
... Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) announ... and CEO, will provide an update on the progress o...nd an overview of the,company,s business strategy ...t the 2008 UBS Global Life Sciences Conference in ...live and may be accessed via a link on,the Sangamo...
...6 Nektar,Therapeutics, (Nasdaq: NKTR ) President...scheduled to present at the upcoming UBS 2008 Glob...nd Hyatt New York Hotel on,Tuesday, September 23, ...accessible via a Webcast through a link posted,on ... the Nektar website:, http://www.nektar.com . This...
... http://www.amdl.com ) AMDL, Inc. (Amex: ADL ), a... major operations in China and the US, announced,t...000 private placement,offering of 10% convertible ...Jesup & Lamont Securities Corporation and Dawson J...and CEO of AMDL, Inc., said, "This financing,stren...
Other Biology Technology:Sangamo BioSciences to Present at the UBS Global Life Sciences Conference 2AMDL, Inc. Closes Private Placement of Convertible Notes 2AMDL, Inc. Closes Private Placement of Convertible Notes 3AMDL, Inc. Closes Private Placement of Convertible Notes 4
(Date:11/30/2009)...to rise scientists are presented with the complex ... adapt. In a paper published in Insect Conservati...and Dr Miguel Rodriguez assess this challenge. , ... 0.6˚C has already affected the Earth,s biota... evolutionary biologists is to predict how biologi...
(Date:11/30/2009)...in the December 2009 print issue of The FASEB Jou...ol over their fertility that women have had since ...w and where androgenic hormones work in the testis...lity. This opens a promising avenue for the develo...fers hope to those who cannot have children becaus...
(Date:11/26/2009)...ers, red deer have been caught in the hunters, sig... more than decorative. They are lethal weapons tha... from The University of York, UK, has been intrigu...alf a century and has become fascinated by the mec...ng collaboration with Tomas Landete-Castillejos at...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2Tough yet stiff deer antler is materials scientist's dream 2And the Beat Goes on 55659 1And the Beat Goes on 55659 2Think zinc 3A Molecular sensor could reveal zincs role in diseases 9732 1Think zinc 3A Molecular sensor could reveal zincs role in diseases 9732 2Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 1Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 2Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 3Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 4Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 5Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 6Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 7Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 8Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 9
...est assured that when you,re asleep they are too. ...9 issue of the journal GENETICS ( http://www.gen...souri-Kansas City have shown that the circadian rh...brates are regulated by some of the same "cellular...ficant because the sleep-regulating enzyme analyze...
...ion to the state of the snow on the slopes, there ...looking closely at a South Pole snowfield this Jan...ted by the UK,s National Physical Laboratory (NPL)... as part of the world,s largest inter-comparison b...ow scientists to fully quantify differences betwee...
...xas is up for a new name, based on Southern Method...r has been misidentified. , State Rep. Charles Ge...nge the name of the state dinosaur from Pleurocoe...e massive sauropod ,whose tracks and bones litter ...scientist behind the name change: His master,s lev...
Other Biology News:When it comes to sleep research, fruit flies and people make unlikely bedfellows 2Satellites search out South Pole snowfields 2A case of mistaken dino-identity 2
GENOMIPHI HY KIT 1000 RXN from GE Healthcare, formerly Amersham Biosciences
N-terminal Sequencing from Primm Biotech, Inc.
Japanese medaka Vitellogenin Standard from Cayman Chemical
I-SAGE Ditag PCR Module* from Invitrogen
Biology Products: